Jaguar Health (JAGX) Retained Earnings (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Retained Earnings of -$391.1 million for Q1 2026, down 55771.43% year-over-year from N/an in Q1 2025, and down 46850.78% quarter-over-quarter from -$833000.0 in Q4 2025.
Jaguar Health (JAGX) Retained Earnings (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Retained Earnings for 13 consecutive years, with -$391.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 55771.43% year-over-year to -$391.1 million; the TTM figure through Mar 2026 stood at -$391.1 million (down 55771.43% YoY), while the FY2025 annual figure was -$833000.0, up 99.76% from the prior year.
- Retained Earnings slipped to -$391.1 million in Q1 2026 per JAGX's latest filing, from -$833000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at -$542000.0 in Q2 2024 and bottomed at -$391.1 million in Q1 2026.
- Historically, Retained Earnings has averaged -$197.2 million across 5 years, with a median of -$259.4 million in 2022.
- On a YoY basis, Retained Earnings climbed as much as 99.78% in 2025 and fell as far as 67677.31% in 2025.
- Jaguar Health's Retained Earnings stood at -$266.9 million in 2022, then soared by 99.76% to -$652000.0 in 2023, then sank by 53041.41% to -$346.5 million in 2024, then soared by 99.76% to -$833000.0 in 2025, then plunged by 46850.78% to -$391.1 million in 2026.
- Business Quant data shows JAGX's Retained Earnings at -$391.1 million in Q1 2026, -$833000.0 in Q4 2025, and -$839000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 4.38 Bn |
| 10 | Jaguar Health | 442,494.54 | -9.62 Mn | 19.11 Mn | -391.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -391.10 Mn |
| Dec 31, 2025 | -833,000.00 |
| Sep 30, 2025 | -839,000.00 |
| Jun 30, 2025 | -367.35 Mn |
| Mar 31, 2025 | -700,000.00 |
| Dec 31, 2024 | -346.48 Mn |
| Sep 30, 2024 | -336.60 Mn |
| Jun 30, 2024 | -542,000.00 |
| Mar 31, 2024 | -317.22 Mn |
| Dec 31, 2023 | -652,000.00 |
| Sep 30, 2023 | -299.10 Mn |
| Jun 30, 2023 | -723,000.00 |
| Mar 31, 2023 | -279.20 Mn |
| Dec 31, 2022 | -266.95 Mn |
| Sep 30, 2022 | -259.40 Mn |
| Jun 30, 2022 | -246.85 Mn |
| Mar 31, 2022 | -237.48 Mn |
| Dec 31, 2021 | -219.49 Mn |
| Sep 30, 2021 | -205.18 Mn |
| Jun 30, 2021 | -192.99 Mn |